Form 4: Neuraxis Director Jane Keyser Receives Stock Award as Compensation
SEC Form 4 Filing
Director Jane Elizabeth Keyser received 11,580 shares of Neuraxis, Inc. common stock as compensation for services provided through March 31, 2024.
Summary
- Jane Elizabeth Keyser, a director of Neuraxis, Inc., received 11,580 shares of common stock on June 28, 2024.
- The shares were issued as compensation for services provided as a board member through March 31, 2024.
- The stock award was granted under an Unrestricted Stock Award Agreement.
- The number of shares was determined by dividing $32,191.78 by the closing price of the common stock on June 28, 2024, which was $2.78 per share.
Sentiment
Score: 7
Explanation: The document reflects a standard compensation practice, indicating stability and alignment of interests. It's a neutral event with a slightly positive implication for corporate governance.
Positives
- The stock award incentivizes the director to continue providing valuable services to the company.
- The award aligns the director's interests with those of the shareholders.
Industry Context
Stock awards are a common form of compensation for directors of publicly traded companies, aligning their interests with shareholders and incentivizing performance.
Stakeholder Impact
- The stock award could have a minor dilutive effect on existing shareholders.
- The award incentivizes the director to act in the best interests of the company and its stakeholders.
Key Dates
| Date | Description |
|---|---|
| 03/31/2024 | End date of service period for which the stock award was granted. |
| 06/28/2024 | Date of the stock award transaction. |
| 07/02/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.